These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 987891)

  • 21. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
    Jung-Hoffmann C; Kuhl H
    Am J Obstet Gynecol; 1987 Jan; 156(1):199-203. PubMed ID: 2948387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 23. Distribution and percentages of non-protein bound contraceptive steroids in human serum.
    Hammond GL; Lähteenmäki PL; Lähteenmäki P; Luukkainen T
    J Steroid Biochem; 1982 Oct; 17(4):375-80. PubMed ID: 6215538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR; Roy S; Mishell DR
    Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M; Morris SE; Groom GV; Jenner DA; Scarisbrick JJ; Cameron EH
    Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of ovarian function after the use of a d-norgestrel-releasing IUD.
    Nilsson CG; Lähteenmäki P
    Contraception; 1977 Apr; 15(4):389-400. PubMed ID: 328225
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
    Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
    Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent.
    Yuzpe AA; Smith RP; Rademaker AW
    Fertil Steril; 1982 Apr; 37(4):508-13. PubMed ID: 7040117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
    Johansson ED; Elamsson K; Elmestedt U
    Gynecol Obstet Invest; 1982; 14(2):97-105. PubMed ID: 6811379
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
    Korkhov VV; Nikanorova SA
    Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of oestradiol on sex hormone binding globulin.
    Odlind V; Elamsson K; Englund DE; Victor A; Johansson ED
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):248-53. PubMed ID: 6814138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on low dose oral contraceptives: plasma hormone changes in relation to deliberate pill ('Microgynon 30') omission.
    Morris SE; Groom GV; Cameron ED; Buckingham MS; Everitt JM; Elstein M
    Contraception; 1979 Jul; 20(1):61-9. PubMed ID: 477318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
    Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
    Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of two estradiol/norgestrel combinations on the ovulatory pattern and on sex hormone binding globulin capacity in women around forty years of age.
    Hagstad A; Damber JE; Janson PO; Samsioe G; Södergård R
    Acta Obstet Gynecol Scand; 1984; 63(4):321-4. PubMed ID: 6540031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral plasma levels of d-norgestrel in women after oral administration of d-norgestrel and when using intravaginal rings impregnated with dl-norgestrel.
    Victor A; Edqvist LE; Lindberg P; Elamsson K; Johansson ED
    Contraception; 1975 Sep; 12(3):261-78. PubMed ID: 1164846
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin.
    Tafurt CA; Sobrevilla LA; de Estrada R
    Fertil Steril; 1980 Mar; 33(3):261-6. PubMed ID: 6767626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.